高级检索
当前位置: 首页 > 详情页

Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy

文献详情

资源类型:
Pubmed体系:
机构: [1]Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China. [2]Indore Institute of Pharmacy, IIST Campus, Rau, Indore-453331, Madhya Pradesh, India. [3]Chitkara College of Pharmacy, Chitkara University, Rajpura-Punjab, India-140401. [4]MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be) University, Mullana-Ambala, Haryana, India. [5]Discipline of Pharmacy Graduate School of Health Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine (ARCCIM) University of Technology Sydney, Sydney, Australia. [6]Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM'S NMIMS, Vile Parle (W), Mumbai-400 056, India. [7]School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab-144411, India.
出处:
ISSN:

关键词: Nanomedicine nanotechnology cancer apoptosis cell proliferation drug delivery

摘要:
Nanomedicine's application of nanotechnology in medicine holds tremendous potential for diagnosing and treating life-threatening diseases such as cancer. Unlike conventional therapies, nanomedicine offers a promising strategy to enhance clinical outcomes while minimizing severe side effects. The principle of drug targeting enables specific delivery of therapeutic agents to their intended sites, making it a more precise and effective therapy. Combination strategies, such as the co-delivery of chemotherapeutic drugs with nucleic acids or receptor-specific molecules, are being employed to enhance therapeutic outcomes. Nanocarriers and drug delivery systems designed using these approaches offer resourceful co-delivery of therapeutic agents for anticancer therapy. Targeted drug delivery via nanotechnology-based techniques has become an urgent need and has shown significant improvements in therapeutic implications, pharmacokinetics, specificity, reduced toxicity, and biocompatibility. This review discusses the extrapolation of nanomaterials for developing innovative and novel drug delivery systems for effective anticancer therapy. Additionally, we explore the role of nanotechnology-based concepts in drug delivery research.Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版
大类 | 4 区 医学
小类 | 3 区 生化与分子生物学 3 区 药物化学 3 区 药学
最新[2023]版
大类 | 4 区 医学
小类 | 3 区 生化与分子生物学 3 区 药物化学 3 区 药学
第一作者:
第一作者机构: [1]Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China. [2]Indore Institute of Pharmacy, IIST Campus, Rau, Indore-453331, Madhya Pradesh, India.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号